Dr. Agarwal's Health Care Limi (AGARWALEYE)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 430.72 460.22 487.42 498.69 529.86
YOY Revenue Growth % - - - - 23.02%
Other Income 12.71 15.43 13.39 7.93 10.54
Total Income 443.43 475.65 500.81 506.62 540.40
Total Expenses + 280.50 414.63 447.21 452.96 475.64
Cost of Materials Consumed 0.39 0.29 0.21 0.19 0.22
Employee Benefit Expense 83.87 87.14 95.52 99.12 105.36
Other Expenses 196.24 198.24 216.40 217.23 233.73
Operating Profit 150.22 45.59 40.21 45.73 54.22
OPM % 34.9% 9.9% 8.2% 9.2% 10.2%
Profit Before Tax + 40.99 58.52 53.60 53.66 64.76
Tax Expense 12.75 15.97 15.54 17.17 21.13
Tax % 31.1% 27.3% 29% 32% 32.6%
Profit After Tax 28.24 42.55 38.06 36.49 43.63
EPS (Basic) 0.73 1.04 0.95 0.94 1.07

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025
Revenue from Operations 1,711.00
YOY Revenue Growth % -
Other Income 46.02
Total Income 1,757.02
Total Expenses + 1,594.15
Cost of Materials Consumed 1.18
Employee Benefit Expense 326.87
Other Expenses 765.65
Operating Profit 116.85
OPM % 6.8%
Profit Before Exceptional 162.87
Exceptional Items -3.02
Profit Before Tax + 159.85
Tax Expense 49.51
Tax % 31%
Profit After Tax 110.34
EPS (Basic) 2.80

Balance Sheet

Particulars Mar 2025
ASSETS
Non-Current Assets + 2,877.50
Property, Plant & Equipment 707.68
Capital Work in Progress 143.88
Non-Current Investments 0.00
Goodwill 734.82
Other Intangible Assets 447.97
Current Assets + 794.07
Inventories 80.27
Trade Receivables 123.56
Cash and Cash Equivalents 103.61
Current Investments 263.73
LIABILITIES & EQUITY
Total Equity 0.00
Equity Share Capital 31.59
Other Equity 1,835.00
Non-Current Liabilities 1,266.99
Current Liabilities 477.76
Total Liabilities 1,744.75

Cash Flow Statement

Particulars Mar 2025
Cash from Operating Activities 360.33
Cash from Investing Activities -750.31
Cash from Financing Activities 381.85
Net Increase/Decrease in Cash -8.13